ARMO BioSciences Announces Poster Presentations of Pegilodecakin (AM0010) at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
ARMO BIOSCIENCES (ARMO)
US:NASDAQ Investor Relations:
armobio.com
Company Research
Source: GlobeNewswire
REDWOOD CITY, Calif., April 25, 2018 (GLOBE NEWSWIRE) -- ARMO BioSciences, Inc. (Nasdaq:ARMO), a late-stage immuno-oncology company, today announced three abstracts on pegilodecakin (AM0010), a long-acting PEGylated form of recombinant human Interleukin-10 (IL-10), have been accepted for poster presentation at the upcoming 2018 ASCO Annual Meeting, taking place June 1-5, 2018 at McCormick Place, in Chicago, Illinois. Title: Overall Survival of PEGylated Pegilodecakin with 5-FU/LV and Oxaliplatin (FOLFOX) in Metastatic Pancreatic Adenocarcinoma (PDAC). Title: Responses and Durability in NSCLC Treated with Pegilodecakin and anti-PD-1 Title: Pegilodecakin with Nivolumab (nivo) or pembrolizumab (pembro) in Patients with Metastatic Renal Cell Carcinoma (RCC) Additional details on the ASCO poster presentations will be announced on May 16, 2018 at 5:00 pm Eastern Time. About ARMO BioSciencesARMO BioSciences is a late-stage immuno-oncology company that is developing a pipeline
Show less
Read more
Impact Snapshot
Event Time:
ARMO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ARMO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ARMO alerts
High impacting ARMO BIOSCIENCES news events
Weekly update
A roundup of the hottest topics